ArticleLiver cancer2026

Lenvatinib Added to Nivolumab and Ipilimumab Improves Tumor Control and Progression-Free Survival in Unresectable Hepatocellular Carcinoma.

Kuan-Chang Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.